Canopy Partners’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-888
Closed -$262K 257
2026
Q1
$262K Sell
888
-69
-7% -$20.5K 0.09% 184
2025
Q4
$261K Buy
957
+126
+15% +$34.2K 0.09% 187
2025
Q3
$225K Sell
831
-79
-9% -$21.5K 0.08% 203
2025
Q2
$251K Buy
910
+45
+5% +$12.2K 0.09% 174
2025
Q1
$229K Sell
865
-6
-0.7% -$1.48K 0.09% 174
2024
Q4
$202K Buy
+871
New +$200K 0.08% 188
2024
Q2
Sell
-1,031
Closed -$222K 201
2024
Q1
$222K Buy
+1,031
New +$217K 0.11% 164

Other funds holding CME

Canopy Partners's CME Position: Q2 2026 in Review

Canopy Partners sold out of CME Group (CME) in Q2 2026, closing a stake of 888 shares — an estimated $262K sold.

Canopy Partners first reported a position in CME in Q1 2024 and held it in 7 quarters. The position peaked at $262K in Q1 2026. 427 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Canopy Partners reported no remaining CME Group position as of Q2 2026 after selling out during the quarter.
  • Canopy Partners sold 888 CME Group shares in Q2 2026, an estimated $262K.
  • Canopy Partners first reported a position in CME Group in Q1 2024 and held it in 7 quarters.
  • Canopy Partners's CME Group position peaked at $262K in Q1 2026.
  • 427 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Canopy Partners's 13F filing for Q2 2026, filed 22 Jul 2026.